Innovative Medicines Canada (IMC) is a Canadian pharmaceutical industry association based in Ottawa, Ontario. It is affiliated with the Health Research Foundation (HRF).[1]
IMC is represented on the board of directors for the Pharmaceutical Advertising Advisory Board (PAAB) by Crawford Wright.[2] It is also partnered with the Best Medicines Coalition.[3]
Current and former member companies of IMC include:[4][5]
Name | Position | Notes |
---|---|---|
Cole Pinnow | Board Chair[6] | Pfizer |
About. Health Research Foundation. Retrieved January 4, 2022, from http://archive.today/2022.01.04-064147/http://www.hrf-frs.com/en/about ↩︎
About. Pharmaceutical Advertising Advisory Board. Retrieved April 24, 2022, from http://archive.today/2018.09.24-200521/https://www.paab.ca/about.htm ↩︎
Support. Best Medicines Coalition. Retrieved August 28, 2022, from https://web.archive.org/web/20220829002642/https://bestmedicinescoalition.org/about/support/ ↩︎
Member Companies. Innovative Medicines Canada. Retrieved April 14, 2021, from https://web.archive.org/web/20210414150341/http://innovativemedicines.ca/about/member-companies/ ↩︎
2019 Annual Report. Innovative Medicines Canada. Retrieved August 28, 2022, from https://web.archive.org/web/20220828174715/https://www.imcannualreport.ca/download/2019AnnualReviewEN.pdf ↩︎
Brophy, E. (2021, November 23). IMC introduces new Chair, Cole Pinnow. Innovative Medicines Canada. http://archive.today/2022.04.28-004838/http://innovativemedicines.ca/cole-pinnow-board-chair/ ↩︎